Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisugabalin in Chinese Patients With Generalized Anxiety Disorder
NCT07330648Phase 2Recruiting
- Sponsor
- Anhui Medical University
- Start
- Oct 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of crisugabalin besilate in generalized anxiety disorder (GAD), sponsored by Anhui Medical University. Started Oct 2025; status: recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT07330648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07330648.